Total Payments
$512.03
2024 Payments
$3.08
Companies
11
Transactions
28
Medicare Patients
2,143
Medicare Billing
$419,023
Payment Breakdown by Category
Food & Beverage$482.04 (94.1%)
Education$29.99 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $482.04 | 24 | 94.1% |
| Education | $29.99 | 4 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $97.71 | 5 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $82.67 | 4 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $70.96 | 4 | $0 (2023) |
| AKEBIA THERAPEUTICS INC | $64.04 | 3 | $0 (2023) |
| Horizon Therapeutics plc | $51.08 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $30.71 | 1 | $0 (2022) |
| Travere Therapeutics, Inc. | $30.40 | 4 | $0 (2024) |
| Amgen Inc. | $22.42 | 1 | $0 (2023) |
| Aurinia Pharma U.S., Inc. | $21.33 | 1 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $20.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3.08 | 1 | Travere Therapeutics, Inc. ($3.08) |
| 2023 | $428.39 | 23 | AstraZeneca Pharmaceuticals LP ($97.71) |
| 2022 | $59.23 | 3 | Gilead Sciences, Inc. ($30.71) |
| 2021 | $21.33 | 1 | Aurinia Pharma U.S., Inc. ($21.33) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/27/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/27/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: CRITICAL CARE | ||||||
| 09/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/16/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: KRYSTEXXA | ||||||
| 08/14/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: NEPHROLOGY | ||||||
| 08/04/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Nephrology | ||||||
| 07/13/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Nephrology | ||||||
| 06/26/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $21.16 | General |
| 06/21/2023 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Nephrology | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/08/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: KRYSTEXXA | ||||||
| 06/07/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/25/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Inflammation | ||||||
| 05/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 05/11/2023 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $20.75 | General |
| Category: NEPHROLOGY | ||||||
| 04/13/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/30/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: KRYSTEXXA | ||||||
| 03/09/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/13/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: NEPHROLOGY | ||||||
| 11/22/2022 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 922 | 1,785 | $630,215 | $175,851 |
| 2022 | 13 | 900 | 1,757 | $631,245 | $178,036 |
| 2021 | 9 | 321 | 527 | $220,592 | $65,137 |
Total Patients
2,143
Total Services
4,069
Medicare Billing
$419,023
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 36 | 285 | $270,750 | $73,279 | 27.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 198 | 474 | $75,366 | $27,496 | 36.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 163 | 184 | $59,064 | $16,996 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 159 | $37,047 | $10,243 | 27.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 108 | $24,408 | $8,962 | 36.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 34 | $32,300 | $7,229 | 22.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 90 | 181 | $17,376 | $6,593 | 37.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 70 | 120 | $43,800 | $6,234 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $18,816 | $5,160 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 106 | $15,688 | $4,901 | 31.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 25 | $11,200 | $3,228 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $9,800 | $3,000 | 30.6% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 15 | 40 | $14,600 | $2,530 | 17.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 52 | 301 | $285,950 | $78,173 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 153 | 368 | $58,512 | $19,208 | 32.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 113 | $50,624 | $15,317 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 79 | 186 | $42,036 | $14,105 | 33.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 124 | 289 | $27,744 | $8,217 | 29.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 82 | 147 | $53,655 | $7,931 | 14.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 67 | 78 | $25,038 | $7,409 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 77 | $17,941 | $6,460 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 38 | 38 | $18,620 | $5,397 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $18,432 | $5,371 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 82 | $12,136 | $5,249 | 43.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 17 | $16,150 | $3,798 | 23.5% |
About Dr. Christin Giordano Mcauliffe, MD
Dr. Christin Giordano Mcauliffe, MD is a Nephrology healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1679894034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christin Giordano Mcauliffe, MD has received a total of $512.03 in payments from pharmaceutical and medical device companies, with $3.08 received in 2024. These payments were reported across 28 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($482.04).
As a Medicare-enrolled provider, Giordano Mcauliffe has provided services to 2,143 Medicare beneficiaries, totaling 4,069 services with total Medicare billing of $419,023. Data is available for 3 years (2021–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Murfreesboro, TN
- Active Since 06/18/2010
- Last Updated 05/26/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679894034
Products in Payments
- Velphoro (Drug) $82.67
- JYNARQUE (Drug) $70.96
- Auryxia (Drug) $64.04
- FARXIGA (Drug) $58.35
- KRYSTEXXA (Biological) $51.08
- TAVNEOS (Drug) $22.42
- LUPKYNIS (Drug) $21.33
- LOKELMA (Drug) $20.91
- RAYALDEE (Drug) $20.75
- TERLIVAZ (Drug) $19.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Murfreesboro
Christie Green, Md, MD
Nephrology — Payments: $10,433
Nephrology $10,433
Jyotheen Karam, M.d, M.D
Nephrology — Payments: $3,594
Nephrology $3,594
Dr. Benjamin Studdard, M.d, M.D
Nephrology — Payments: $3,089
Nephrology $3,089
Ann Herron, Md, MD
Nephrology — Payments: $332.43
Nephrology $332.43
Dr. Taylor Chaney, Do, DO
Nephrology
Nephrology